BioSig Technologies, Inc.
BSGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $13 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $554 | $21 | $0 |
| Gross Profit | $0 | -$554 | -$21 | $13 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $6 | $19 | $6 | $96 |
| G&A Expenses | $4,619 | $19,792 | $2,957 | $1,070 |
| SG&A Expenses | $4,619 | $19,792 | $2,957 | $1,070 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,488 | $554 | $21 | $30 |
| Operating Expenses | $6,113 | $20,365 | $2,984 | $1,196 |
| Operating Income | -$6,113 | -$20,365 | -$2,984 | -$1,183 |
| % Margin | – | – | – | -9,100% |
| Other Income/Exp. Net | -$10,236 | -$3 | $184 | $84 |
| Pre-Tax Income | -$16,349 | -$20,368 | -$2,800 | -$1,099 |
| Tax Expense | -$765 | $0 | $0 | $0 |
| Net Income | -$15,584 | -$20,372 | -$2,812 | -$1,099 |
| % Margin | – | – | – | -8,453.8% |
| EPS | -0.47 | -0.74 | -0.02 | -0.008 |
| % Growth | 36.5% | -3,600% | -156.4% | – |
| EPS Diluted | -0.47 | -0.74 | -0.02 | -0.008 |
| Weighted Avg Shares Out | 333,520 | 277,068 | 140,417 | 140,417 |
| Weighted Avg Shares Out Dil | 333,520 | 277,068 | 140,417 | 140,417 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $13 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $3 |
| Depreciation & Amortization | $1,488 | $554 | $21 | $30 |
| EBITDA | -$14,861 | -$19,809 | -$2,779 | -$2,311 |
| % Margin | – | – | – | -17,776.9% |